Items where Author is "Tanbin, Suriyea"

Article

Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea (2021) Enhanced expression and purification strategy for recombinant bacterially-expressed human hexokinase II. Molekul, 16 (1). pp. 82-91. ISSN 1907-9761 E-ISSN 2503-0310

Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani and Abdul Hamid, Azzmer Azzar (2021) Virtual screening for potential inhibitors of human hexokinase II for the development of anti-dengue therapeutics. BioTech, 10 (1). pp. 1-28. ISSN 2673-6284

Asman, Nur Atikah and Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani (2020) Effects of Daidzin and analogue of Ganoderma sinense on bacterially-expressed human hexokinase isoform 2 for anti-dengue drug design. Biological And Natural Resources Engineering Journal, 3 (2). pp. 27-34. E-ISSN 2637-0719

Tanbin, Suriyea and Ogu Salim, Nurhainis and Ahmad Fuad, Fazia Adyani (2019) Identifying analogues of 2-deoxyglucose, alpha-d-glucose and beta-d-glucose-6-phosphate as potential inhibitors of human hexokinase ii for the development of anti-dengue therapeutics. Pertanika Journal of Science and Technology, 27 (4). pp. 1625-1647. ISSN 0128-7680

Ahammad, Foysal and Tengku Abd Rashid, Tengku Rogayah and Mohamed, Maizan and Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani (2019) Contemporary strategies and current trends in designing antiviral drugs against dengue fever via targeting host-based approaches. Microorganisms, 7 (9). pp. 1-28. ISSN 2076-2607

Proceeding Paper

Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea and Ogu Salim, Nurhainis (2022) The glycolytic pathway is a target for drug discovery against tropical diseases. In: The 4th International Conference on Biosciences & Medical Engineering, 21-22 June 2022, IIUM Gombak ( Virtual Conference). (Unpublished)

Che Abdul Aziz, Faqihah Izzati and Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea (2021) Virtual screening and in silico Interactions studies for potential antivirals and diagnostics against the spike protein from the Novel Coronavirus SARS-Cov-2. In: 6th International Conference on Biotechnology Engineering (ICBioE 2021), 22-23 June 2021, Kuala Lumpur (Virtual).

Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani (2020) Novel compounds as potential anti-dengue therapies verified via inhibition of human hexokinase isoform II. In: Kulliyyah of Engineering Research, Innovation and Commercialization Exhibition 2020 (KERICE '20), 8th Dec. 2020, Virtual Platform. (Unpublished)

Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea (2020) Interrogating novel compounds for improved anti-dengue therapies via inhibition of human hexokinase II (HKII). In: Nanotechnology Symposium 2020, 21st Feb. 2020, Kuala Lumpur, Malaysia. (Unpublished)

Tanbin, Suriyea and Mohd Razali, Nur Izzati and Ahmad Fuad, Fazia Adyani (2019) Elucidating the analogues of 3-bromopyruvate (3-BP) as inhibitors against human hexokinase II for the development of anti-dengue drugs. In: 8th International Molecular Biology And Biotechnology Congress (MOLBIOTECH), 17 - 20 Dec 2019, Afyon, Turkey.

Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani and Abdul Hamid, Azzmer Azzar (2019) Potential inhibitors of Human Hexokinase II for the development of anti-dengue therapeutics identified via in silico approach. In: Kuliyyah of Engineering Research, Innovation and Commercialization Exhibition 2019 (KERICE 2019), 18th September 2019, KOE, IIUM. (Unpublished)

Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani (2019) Expression and purification of soluble bacterially-expressed human hexokinase II in E.coli system. In: "9th International Conference on Biomedical Engineering and Technology, ICBET 2019", 28 - 30 Mar 2019, Meiji UniversityTokyo, Japan.

Tanbin, Suriyea and Ogu Salim, Nurhainis and Ahmad Fuad, Fazia Adyani (2018) Analogues of 2-Deoxyglucose as inhibitor candidates for hexokinase II identified via virtual screening analyses. In: 5th International Conference on Biotechnology Engineering (ICBioE 2018), 19th-20th September 2018, Kuala Lumpur.